MS CONTIN Drug Patent Profile

✉ Email this page to a colleague

When do Ms Contin patents expire, and what generic alternatives are available?

Ms Contin is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in MS CONTIN is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ms Contin

A generic version of MS CONTIN was approved as morphine sulfate by HOSPIRA on September 30^th, 1992.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MS CONTIN?
What are the global sales for MS CONTIN?
What is Average Wholesale Price for MS CONTIN?

Summary for MS CONTIN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	24
Clinical Trials:	7
Patent Applications:	2,931
Drug Prices:	Drug price information for MS CONTIN
What excipients (inactive ingredients) are in MS CONTIN?	MS CONTIN excipients list
DailyMed Link:	MS CONTIN at DailyMed

Drug patent expirations by year for MS CONTIN

Recent Clinical Trials for MS CONTIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical University Innsbruck	Phase 2
National Institute of Nursing Research (NINR)	Phase 4
Ranbaxy Inc.	Phase 1

See all MS CONTIN clinical trials

Pharmacology for MS CONTIN

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

US Patents and Regulatory Information for MS CONTIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-003	Sep 12, 1989	AB	RX	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-004	Jan 16, 1990	AB	RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-001	May 29, 1987	AB	RX	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MS CONTIN

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-005	Nov 8, 1993	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-003	Sep 12, 1989	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-004	Jan 16, 1990	4,366,310	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MS CONTIN

See the table below for patents covering MS CONTIN around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Denmark	170347		⤷ Subscribe
Greece	72265		⤷ Subscribe
Norway	803836		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for MS CONTIN

Recent Clinical Trials for MS CONTIN

Pharmacology for MS CONTIN

Make Better Decisions: Try a trial or see plans & pricing